written on 02.04.2014

ViiV adds pricey new HIV drug Tivicay to patent pool


GlaxoSmithKline CEO Andrew Witty set a precedent back in 2009, when his company placed several patents in a public pool to help developing countries find cures for HIV and other diseases–and then challenged other companies to do the same.